Who owns Adverum Biotechnologies, Inc.?
- Ticker: ADVM
- CUSIP Number: 00773u207
Tip: Access positions for across all investors
Analyze quarterly positions in Adverum Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adverum Biotechnologies stock
Who bought or sold Adverum Biotechnologies, Inc. this quarter?
There are no current stakeholders of Adverum Biotechnologies.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Adverum Biotechnologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Principia Wealth Advisory | Sep 2025 | 2.1M | $9.4M |
| Vanguard Group | Sep 2025 | 872k | $4.0M |
| Renaissance Technologies | Sep 2025 | 364k | $1.6M |
| Pale Fire Capital SE | Sep 2025 | 363k | $1.6M |
| Warren Averett Asset Management | Sep 2025 | 161k | $729k |
| State Street Corporation | Sep 2025 | 69k | $311k |
| Susquehanna International | Sep 2025 | 58k | $260k |
| Quinn Opportunity Partners | Sep 2025 | 41k | $188k |
| Marshall Wace | Sep 2025 | 28k | $129k |
| Northern Trust | Sep 2025 | 28k | $127k |
| Qube Research & Technologies | Sep 2025 | 22k | $98k |
| Royal Bank of Canada | Sep 2025 | 14k | $50k |
| XTX Topco | Sep 2025 | 13k | $57k |
| FMR | Sep 2025 | 1.9k | $8.8k |
| Advisor Group Holdings | Sep 2025 | 1.7k | $7.7k |
| Jones Financial Companies, L.L | Sep 2025 | 1.0k | $4.5k |
| Jpmorgan Chase & Co | Sep 2025 | 182.00 | $824.005000 |